OZEMPIC 1 mg, solution for injection in a pre-filled pen pen, 3 ml + 4 needles
Brand page: Ozempic (semaglutide) — all forms and strengths in France
Active ingredients: Semaglutide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 3 ml + 4 needlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OZEMPIC 1 mg, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 cartouche en verre de 3 mL dans stylo pré-rempli multidose jetable + 4 aiguilles
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- 30 %
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Diabète dit de type 2, en association avec certains médicaments uniquement (soit avec la metformine, soit avec la metformine ou un sulfamide hypoglycémiant) ; JOURNAL OFFICIEL ; 17/04/19
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Apr 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63210923CIP73015110CIP133400930151105Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SÉMAGLUTIDEsolution | 1 mg · une dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.